Literature DB >> 4933319

Adjuvant-induced antired blood cell activity in CBA mice.

A McCracken, W H McBride, D M Weir.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4933319      PMCID： PMC1713043     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  9 in total

1.  [The anemia of rheumatoid arthritis].

Authors:  W R ALEXANDER; J J DUTHIE
Journal:  Arch Interam Rheumatol       Date:  1962-09

2.  Hyperactivity of the reticuloendothelial system and experimental anemia in mice.

Authors:  F GORSTEIN; B BENACERRAF
Journal:  Am J Pathol       Date:  1960-11       Impact factor: 4.307

3.  A modification of the hemolytic plaque assay for use with protein antigens.

Authors:  E S Golub; R I Mishell; W O Weigle; R W Dutton
Journal:  J Immunol       Date:  1968-01       Impact factor: 5.422

4.  Factors influencing the immune response. 3. The blocking effect of Corynebacterium parvum upon the induction of acquired immunological unresponsiveness to bovine serum albumin in the adult rabbit.

Authors:  R N Pinckard; D M Weir; W H McBride
Journal:  Clin Exp Immunol       Date:  1968-06       Impact factor: 4.330

5.  Isolation of diphtheroid bacilli from synovial membrane and fluid in rheumatoid arthritis.

Authors:  S M Stewart; W R Alexander; J J Duthie
Journal:  Ann Rheum Dis       Date:  1969-09       Impact factor: 19.103

6.  [Activation of autoimmune hemolytic anemia in young NZB mice by administration of Corynebacterium parvum].

Authors:  B Halpern; A Fray
Journal:  Ann Inst Pasteur (Paris)       Date:  1969-12

7.  Comparative effect of two strains of C. parvum on phagocytic activity and tumour growth.

Authors:  L H Smith; M F Woodruff
Journal:  Nature       Date:  1968-07-13       Impact factor: 49.962

8.  Increased nonspecific resstance to malaria produced by administration of killed Corynebacterium parvum.

Authors:  R S Nussenzweig
Journal:  Exp Parasitol       Date:  1967-10       Impact factor: 2.011

9.  Inhibition of tumour growth by administration of killed corynebacterium parvum.

Authors:  B N Halpern; G Biozzi; C Stiffel; D Mouton
Journal:  Nature       Date:  1966-11-19       Impact factor: 49.962
  9 in total
  8 in total

1.  Haematological changes and iron metabolism in rats after administration of Corynebacterium parvum.

Authors:  B Brozovic; V S Sljivić; G W Warr
Journal:  Br J Exp Pathol       Date:  1975-04

2.  Studies of the Corynebacterium parvum-associated anaemia in mice.

Authors:  K O Cox; D Keast
Journal:  Clin Exp Immunol       Date:  1974-05       Impact factor: 4.330

3.  Increased phagocytic cell activity and anaemia in Corynebacterium parvum treated mice.

Authors:  W H McBride; J T Jones; D M Weir
Journal:  Br J Exp Pathol       Date:  1974-02

4.  The role of anaerobic coryneforms on specific and non-specific immunological reactions. I. Effect on particle clearance and humoral and cell-mediated immunological responses.

Authors:  G J O'Neill; D C Henderson; R G White
Journal:  Immunology       Date:  1973-06       Impact factor: 7.397

5.  Activation of the classical and alternate pathways of complement by Corynebacterium parvum.

Authors:  W H McBride; D M Weir; A B Kay; D Pearce; J R Caldwell
Journal:  Clin Exp Immunol       Date:  1975-01       Impact factor: 4.330

6.  Dichotomy between macrophage activation and degree of protection against Listeria monocytogenes and Toxoplasma gondii in mice stimulated with Corynebacterium parvum.

Authors:  J E Swartzberg; J L Krahenbuhl; J S Remington
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

7.  Mechanisms of C. Parvum-induced coagulopathy in mice.

Authors:  H D Mitcheson; P Hilgard; A McCraw; J E Castro
Journal:  Br J Cancer       Date:  1980-01       Impact factor: 7.640

8.  The effect of Corynebacterium parvum therapy on immunoglobulin class and IgG subclass levels in cancer patients.

Authors:  K James; G J Clunie; M F Woodruff; W H McBride; W H Stimson; R Drew; D Catty
Journal:  Br J Cancer       Date:  1975-09       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.